About
Mr. Pascal Soriot, M.B.A., D.V.M., served as Director at Acerta Pharma B.V. He joined Acerta Pharma in January 2018 as Vice President Research Europe & Site Head of Acerta’s R&D site in The Netherlands. Dr Stam has over 25 years of experience in pharmaceutical industry, and held executive positions in business development & licensing, R&D portfolio management, strategy, merger & acquisition research, and R&D at Merck & Co, Schering-Plough, and Organon. He had been Independent Non-Executive Director at CSL Limited since August 19, 2020 until January 31, 2021. Mr. Soriot has been the Chief Executive Officer and Executive Director at AstraZeneca PLC since October 1, 2012.
Mr. Soriot served as the Chief Operating Officer of Roche Pharma AG from 2010 to September 1, 2012. He served as the Chief Operating Officer of Roche Pharmaceuticals at Roche Diabetes Care AG from 2010 to September 2012. He served as the Chief Operating Officer of Pharmaceuticals at Roche Holding AG since January 1, 2010 and served as its Head of Pharma Medicines. He served as the Chief Executive Officer of Genentech Inc. since 2009. He served as the Head of Commercial Operations at Roche Holding AG since December 2006 and Head of Strategic Marketing Pharma Division from March 1, 2006 to December 2006.
He served as Senior Vice President of Commercial Operations, United States of Sanofi-aventis since August 2004 and Chief Operating Officer since 2002. Before joining sanofi-aventis, he served in a similar position at Aventis. After being appointed by Roussel Uclaf in 1986 as Financial Controller for the Asia-Pacific region, he held various management positions in finance and marketing at companies that form part of sanofi-aventis. He served as District Sales Manager at Roussel New Zealand since 1987. He served as Sales and Marketing Manager at Roussel Australia since 1989 and also served as its General Manager. He served as Division Global Marketing Director at Roussel Uclaf Pharmaceuticals since 1994 and General Manager at Hoechst Marion Roussel Australia since 1996. He served as Regional Vice President, Asia Pacific at Hoechst Marion Roussel Tokyo since 1997.
He served as Senior Vice President and Head of Global Marketing & Medical Affairs at Aventis Bridgewater (US) since 2000 and Head of Strategic Marketing at Roche since 2006 and as its Head of Commercial Operations since 2007. Mr. Soriot has worked in a variety of senior pharmaceutical management roles in France, Switzerland, Japan, Australia and the United States. He served as a Director of Genentech, Inc. He served as a Director of Chugai Pharmaceutical Co. Ltd. until September 3, 2012.
He served as a Director of Viela Bio, Inc. since October 2019 until August 2020. He holds a Doctoral degree in Veterinary Medicine from the Ecole Nationale Vtrinaire at Maisons-Alfort and an MBA with major in Finance from French Business School, HEC Paris (Ecole des Hautes Etudes Commerciales – Institut Suprieur des Affaires). Dr Stam received an MSc degree in Chemistry, and a PhD in immunology/cancer research from the Free University Amsterdam & Netherlands Cancer Institute.
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| AstraZeneca PLC | Board | Member | 01/01/2012 |